Regulations: Good Clinical Practice and Clinical Trials - FDA

You agree never to divulge classified information unless the recipient is authorized by the USG to receive it. 2. Pharma: 21 CFR Part 312 (IND Applications)

Investigators must supervise the administration of the drug and ensure it is only given to authorized subjects.